Firazyr - 54092-702-03 - (icatibant acetate)

Alphabetical Index


Drug Information of Firazyr

Product NDC: 54092-702
Proprietary Name: Firazyr
Non Proprietary Name: icatibant acetate
Active Ingredient(s): 30    mg/3mL & nbsp;   icatibant acetate
Administration Route(s): SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Firazyr

Product NDC: 54092-702
Labeler Name: Shire US Manufacturing Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022150
Marketing Category: NDA
Start Marketing Date: 20110825

Package Information of Firazyr

Package NDC: 54092-702-03
Package Description: 3 SYRINGE, GLASS in 1 CARTON (54092-702-03) > 3 mL in 1 SYRINGE, GLASS

NDC Information of Firazyr

NDC Code 54092-702-03
Proprietary Name Firazyr
Package Description 3 SYRINGE, GLASS in 1 CARTON (54092-702-03) > 3 mL in 1 SYRINGE, GLASS
Product NDC 54092-702
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name icatibant acetate
Dosage Form Name INJECTION, SOLUTION
Route Name SUBCUTANEOUS
Start Marketing Date 20110825
Marketing Category Name NDA
Labeler Name Shire US Manufacturing Inc.
Substance Name ICATIBANT ACETATE
Strength Number 30
Strength Unit mg/3mL
Pharmaceutical Classes Bradykinin B2 Receptor Antagonist [EPC],Bradykinin B2 Receptor Antagonists [MoA]

Complete Information of Firazyr


General Information